Arquer Diagnostics

is a UK-based company committed to manufacturing

and marketing innovative, non-invasive

cancer tests for diagnosis and monitoring

VISION

Inspiring transformational change in the

field of oncology diagnostics

MISSION

To develop and deliver accurate, rapid, minimally

invasive oncology diagnostic products utilising our

patented MCM5 antibodies

Arquer Diagnostics is leading the way in non-invasive tests for diagnosing and monitoring cancer.
Our tests use patented technology to detect the presence of a protein produced by the expression of the MCM5 (Minichromosome Maintenance Complex Component 5) gene.

Our accurate and reliable tests meet the demands of patients, clinicians and payers for non-invasive, pain-free, healthcare technologies which not only improve patient care but reduce healthcare costs.

ADXBLADDER is the first of Arquer’s MCM5 tests to be released as a CE marked bladder cancer test and we are also currently testing the technology in prostate and endometrial cancers.

ADXBLADDER

MCM5 ELISA KIT


MCM Technology



Latest News

A MESSAGE
FOR PATIENTS

ADXBLADDER is only available via a Urologist. Please contact yours to discuss its availability in your local NHS hospital, or privately.

If you are not under a Urologist’s care then please talk to your GP for a referral.

Alternatively you can
contact us here.